GLP1R and type 1 diabetes mellitus: Mohandas et al. [111] conducted a real-world retrospective chart review study on a cohort of 54 adult patients with long-standing T1D who had been on long-acting GLP-1 RAs (including semaglutide, exenatide extended-release, dulaglutide, albiglutide) for at least 6 months.